News

A novel approach to treat platinum/taxane-resistant ovarian cancer by combining ixabepilone and bevacizumab has shown promise in extending survival times.

A new study has found that in order to form organs, the back ends of moving cell groups push the group into place.

A new treatment for muscle-invasive bladder cancer in patients that are ineligible for cisplatin treatment is being trialled.

Researchers have developed a novel drug delivery system using corn that can be used to target cancer cells directly, via an immune mechanism.

A team from the University of Helsinki has uncovered how ovarian cancer hides from the immune system. The findings will help to design new precision therapies for ovarian cancer.

Researchers show that the protein ΔNp63 contributes to lung cancer development through the regulation of stem cells and enhancers, which regulate genes that control cell identity.

A molecular cage has been designed to surround cancer proteins and make them easier to visualize with cryo-electron microscopy, enabling insights into their structure previously not possible.

A study has shown how two subsets of the CD8 T cell develop to provide either short-term or long-term immune protection.

Researchers from Vanderbilt University have discovered how polyps develop into colorectal cancer. This knowledge could help to improve how this type of cancer is monitored and treated. The study was published in Cell.

Researchers have clarified the role of a recurring cancer-associated tumor mutation in the most common and most aggressive type of malignant brain tumor, glioblastoma multiforme.